Disease Domain | Count |
---|---|
Immune System Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 1 |
Top 5 Target | Count |
---|---|
c-Kit(Stem cell growth factor receptor) | 1 |
Target |
Mechanism c-Kit inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date01 May 2024 |
Sponsor / Collaborator |
Start Date04 Jan 2023 |
Sponsor / Collaborator |
Start Date11 Oct 2022 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
MOD000001 ( c-Kit ) | Anaphylaxis More | Preclinical |